Vaccinations in patients with multiple sclerosis: a real-world, single-center, experience

被引：0
|
作者：
Sbragia, E. [1 ]
Olobardi, D. [2 ,3 ,4 ]
Novi, G. [5 ]
Lapucci, C. [1 ]
Cellerino, M. [1 ]
Boffa, G. [1 ]
Laroni, A. [1 ]
Mikulska, M. [6 ,7 ]
Sticchi, L.
Inglese, M. [1 ]
机构：
[1] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet Maternal &, Genoa, Italy
[2] Osped Policlin San Martino IRCCS, Hyg Unit, Genoa, Italy
[3] Osped Policlin San Martino IRCCS, Dept Hlth Sci DiSSal, Genoa, Italy
[4] Univ Genoa, Genoa, Italy
[5] IRCCS Osped Policlin San Martino, Dept Neurol, Genoa, Italy
[6] Univ Genoa, Div Infect Dis, Genoa, Italy
[7] Osped Policlin San Martino, Genoa, Italy
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2022年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPO-643
引用
收藏
页码：788 / 788
页数：1
相关论文
共 50 条
  • [31] Real-world effectiveness and safety of bosentan in Japanese patients with systemic sclerosis: A single-center retrospective study
    Ishikawa, Mai
    Endo, Yukie
    Yamazaki, Sahori
    Sekiguchi, Akiko
    Uchiyama, Akihiko
    Motegi, Sei-ichiro
    JOURNAL OF DERMATOLOGY, 2023, 50 (06): : 828 - 832
  • [32] Real-world outcomes and toxicity of adjuvant chemotherapy in NSCLC: a single-center experience
    Cronin, Christopher
    Iqbal, Shahid
    Farooq, Abdul R.
    O'Dea, Pauline
    Burke, Louise
    O'Reilly, Seamus
    O'Mahony, Deirdre
    Power, Derek G.
    Bambury, Richard M.
    Collins, Dearbhaile C.
    LUNG CANCER MANAGEMENT, 2023, 12 (01)
  • [33] Real-world experience of ocrelizumab in MS in the Turkish population: A single-center study
    Koc, E.
    Saridas, F.
    Ceylan, D.
    Turan, O.
    Ozkaya, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 792 - 792
  • [34] Cost of transcatheter aortic valve implantation in the real-world: a single-center experience
    Costopoulos, Charis
    Frame, Angela
    Mikhail, Ghada
    Sutaria, Nilesh
    Ariff, Ben
    Anderson, Jon
    Chukwuemeka, Andrew
    Malik, Iqbal S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (11) : B218 - B219
  • [35] REAL-WORLD DATA ON EMICIZUMAB PROPHYLAXIS IN THE MILAN COHORT: A SINGLE-CENTER EXPERIENCE
    Arcudi, S.
    Gualtierotti, R.
    Ciavarella, A.
    Marino, S.
    Siboni, S.
    Biguzzi, E.
    Boccalandro, E.
    Begnozzi, V.
    Schiavone, L.
    Novembrino, C.
    Valsecchi, C.
    Peyvandi, F.
    HAEMOPHILIA, 2022, 28 : 84 - 84
  • [36] Real-world clinical experience of secukinumab in Chinese patients with psoriasis in real-world practice: a 36-week single-center study of 24 patients
    Zhang Jing
    Ji Chao
    Cheng Bo
    Ruan Shi-Fan
    Liu Tao
    Huang Jin-Wen
    中华医学杂志英文版, 2020, 133 (24) : 3020 - 3022
  • [37] Real-world clinical experience of secukinumab in Chinese patients with psoriasis in real-world practice: a 36-week single-center study of 24 patients
    Zhang, Jing
    Ji, Chao
    Cheng, Bo
    Ruan, Shi-Fan
    Liu, Tao
    Huang, Jin-Wen
    CHINESE MEDICAL JOURNAL, 2020, 133 (24) : 3020 - 3022
  • [38] Treatment patterns of patients with multiple sclerosis in China: A single-center experience
    Li, Rui
    Wang, Jingqi
    Li, Jing
    Wang, Yuge
    Wu, Haotian
    Fan, Ping
    Zhong, Xiaonan
    Lau, Alexander Y.
    Kermode, Allan G.
    Qiu, Wei
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (09) : NP45 - NP46
  • [39] Real-world experience of ocrelizumab in multiple sclerosis patients in latin america
    Rojas, J.
    Patrucco, L.
    Fruns, M.
    Flores-Rivera, J.
    Carnero Contentti, E.
    Galleguillos, L.
    Alonso, R.
    Cristiano, E.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 548 - 548
  • [40] Real-world experience of ocrelizumab in multiple sclerosis patients in Latin America
    Ignacio Rojas, Juan
    Patrucco, Liliana
    Fruns, Manuel
    Hornung, Giesela
    Flores, Jose
    Carnero Contentti, Edgar
    Adrian Lopez, Pablo
    Pablo Pettinicchi, Juan
    Caride, Alejandro
    Galleguillos, Lorna
    Barahona, Jorge
    Diaz, Violeta
    Hernandez, Marianella
    Alonso, Ricardo
    Cristiano, Edgardo
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2021, 79 (04) : 305 - 309
12345